Broad spectrum of ED treatments waits in the wings
Rome-The prospects for safe and effective therapy for male erectiledysfunction have never looked brighter, according to experts speaking atthe 4th Congress of the European Society for Sexual and Impotence Researchhere. Results from clinical trials of new oral medications are particularlypromising, but research on other, non-oral agents also showed promise inpatients who fail to respond to oral treatment.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.